What does the Gland Pharma Limited (GLAND) stock page cover?

Gland Pharma Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for GLAND?

Gland Pharma Limited is currently shown with a delayed price near ₹3,095.9, P/E 45.2.

Does the GLAND page provide investment advice?

No. The GLAND page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Stocks›Healthcare

Watch Alert

Gland Pharma Limited

GLAND · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹3,095.90

+₹21.40 (+0.70%)(1D)

₹1,573.6052 Week Range₹3,171.00

Anvest Score

59/100

Valuation

23/100

Quality

50/100

Growth

86/100

Health

99/100

Momentum

45/100

Valuation
23
Quality
50
Growth
86
Health
99
Momentum
45

Loading company profile…

More Page Context

Research at a glance

Gland Pharma Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹3,095.9

Market cap

₹51,014 Cr

P/E ratio

45.2

P/B ratio

4.93

Dividend yield

Not available

ROE

Not available

RSI 14

59.97

1Y return

Not available